Clinical trials
Dyslipidemias trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
344 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 8 |
| 2004 | 6 |
| 2005 | 20 |
| 2006 | 30 |
| 2007 | 19 |
| 2008 | 24 |
| 2009 | 8 |
| 2010 | 16 |
| 2011 | 19 |
| 2012 | 14 |
| 2013 | 12 |
| 2014 | 16 |
| 2015 | 5 |
| 2016 | 16 |
| 2017 | 12 |
| 2018 | 11 |
| 2019 | 8 |
| 2020 | 13 |
| 2021 | 8 |
| 2022 | 10 |
| 2023 | 14 |
| 2024 | 17 |
| 2025 | 9 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 268 |
| Terminated | 24 |
| Recruiting | 17 |
| Active, not recruiting | 10 |
| Unknown status | 9 |
| Not yet recruiting | 5 |
| Suspended | 4 |
| Withdrawn | 4 |
| Enrolling by invitation | 2 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 23 |
| Takeda | 23 |
| Pfizer | 11 |
| UCSF Benioff Children's Hospital Oakland | 10 |
| Eli Lilly and Company | 9 |
| Abbott | 7 |
| Amgen | 7 |
| Kowa Research Institute, Inc. | 7 |
| National Heart, Lung, and Blood Institute (NHLBI) | 7 |
| NewAmsterdam Pharma | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 344 |
| Hypertension | 70 |
| Diabetes Mellitus | 63 |
| Obesity | 63 |
| Hyperlipidemias | 58 |
| Hypercholesterolemia | 54 |
| Cardiovascular Diseases | 45 |
| Diabetes Mellitus, Type 2 | 45 |
| Metabolic Syndrome | 33 |
| Insulin Resistance | 29 |
Trials
Showing 51 to 75 of 344. Each trial links to its page on Pharma Observatory.
244 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.